Search research articles
Contact Us
Filters
Showing results (241-250 of 536) with videos related to
Page
of 54
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2008
A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents
Rosa Lapalombella, Xiaobin Zhao, Georgia Triantafillou, et al.
Leukemia & Lymphoma
|
October 26, 2022
Venetoclax-based salvage therapy in patients with relapsed/refractory acute myeloid leukemia previously treated with FLT3 or IDH1/2 inhibitors
Jan Philipp Bewersdorf, Rory M Shallis, Andriy Derkach, et al.
American Journal of Hematology
|
February 8, 2022
High prevalence and inferior long-term outcomes for TP53 mutations in therapy-related acute lymphoblastic leukemia
Hoda Pourhassan, Dongyun Yang, Michelle Afkhami, et al.
Cancer
|
June 30, 2012
Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802
Wendy Stock, Jeffrey L Johnson, Richard M Stone, et al.
International Journal of Molecular Sciences
|
August 10, 2024
Discovery of NFκB2-Coordinated Dual Regulation of Mitochondrial and Nuclear Genomes Leads to an Effective Therapy for Acute Myeloid Leukemia
Yi Xu, David J Baylink, Jeffrey Xiao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 14, 2009
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies
Mehdi Hamadani, William Blum, Gary Phillips, et al.
Research Square
|
November 1, 2024
Phase I First-in-Human Dose Escalation Study of the oral Casein Kinase 1α and Cyclin Dependent Kinase 7/9 inhibitor BTX-A51 in advanced MDS and AML
Brian Ball, Wenbin Xiao, Gautam Borthakur, et al.
Molecular Therapy. Nucleic Acids
|
August 22, 2024
Bi-functional CpG-STAT3 decoy oligonucleotide triggers multilineage differentiation of acute myeloid leukemia in mice
Dongfang Wang, Damian Kaniowski, Karol Jacek, et al.
British Journal of Haematology
|
October 15, 2014
Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis
Naval Daver, Hagop Kantarjian, Guido Marcucci, et al.
Frontiers in Oncology
|
November 17, 2022
Role of radiotherapy in treatment of extramedullary relapse following total marrow and lymphoid irradiation in high-risk and/or relapsed/refractory acute leukemia
Colton Ladbury, Hemal Semwal, Daniel Hong, et al.
Page
of 54
Search research articles
Search
Showing results (241-250 of 536) with videos related to
Sort By:
Page
of 54
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2008
A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents
Rosa Lapalombella, Xiaobin Zhao, Georgia Triantafillou, et al.
Leukemia & Lymphoma
|
October 26, 2022
Venetoclax-based salvage therapy in patients with relapsed/refractory acute myeloid leukemia previously treated with FLT3 or IDH1/2 inhibitors
Jan Philipp Bewersdorf, Rory M Shallis, Andriy Derkach, et al.
American Journal of Hematology
|
February 8, 2022
High prevalence and inferior long-term outcomes for TP53 mutations in therapy-related acute lymphoblastic leukemia
Hoda Pourhassan, Dongyun Yang, Michelle Afkhami, et al.
Cancer
|
June 30, 2012
Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802
Wendy Stock, Jeffrey L Johnson, Richard M Stone, et al.
International Journal of Molecular Sciences
|
August 10, 2024
Discovery of NFκB2-Coordinated Dual Regulation of Mitochondrial and Nuclear Genomes Leads to an Effective Therapy for Acute Myeloid Leukemia
Yi Xu, David J Baylink, Jeffrey Xiao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 14, 2009
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies
Mehdi Hamadani, William Blum, Gary Phillips, et al.
Research Square
|
November 1, 2024
Phase I First-in-Human Dose Escalation Study of the oral Casein Kinase 1α and Cyclin Dependent Kinase 7/9 inhibitor BTX-A51 in advanced MDS and AML
Brian Ball, Wenbin Xiao, Gautam Borthakur, et al.
Molecular Therapy. Nucleic Acids
|
August 22, 2024
Bi-functional CpG-STAT3 decoy oligonucleotide triggers multilineage differentiation of acute myeloid leukemia in mice
Dongfang Wang, Damian Kaniowski, Karol Jacek, et al.
British Journal of Haematology
|
October 15, 2014
Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis
Naval Daver, Hagop Kantarjian, Guido Marcucci, et al.
Frontiers in Oncology
|
November 17, 2022
Role of radiotherapy in treatment of extramedullary relapse following total marrow and lymphoid irradiation in high-risk and/or relapsed/refractory acute leukemia
Colton Ladbury, Hemal Semwal, Daniel Hong, et al.
Page
of 54